Cargando…

De Novo Donor‐Specific HLA Antibody Formation in Two Patients With Crigler‐Najjar Syndrome Type I Following Human Hepatocyte Transplantation With Partial Hepatectomy Preconditioning

Clinical hepatocyte transplantation is hampered by low engraftment rates and gradual loss of function resulting in incomplete correction of the underlying disease. Preconditioning with partial hepatectomy improves engraftment in animal studies. Our aim was to study safety and efficacy of partial hep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jorns, C., Nowak, G., Nemeth, A., Zemack, H., Mörk, L.‐M., Johansson, H., Gramignoli, R., Watanabe, M., Karadagi, A., Alheim, M., Hauzenberger, D., van Dijk, R., Bosma, P. J., Ebbesen, F., Szakos, A., Fischler, B., Strom, S., Ellis, E., Ericzon, B.‐G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061095/ https://www.ncbi.nlm.nih.gov/pubmed/26523372 http://dx.doi.org/10.1111/ajt.13487

Ejemplares similares

Management of Crigler-Najjar syndrome
por: Tcaciuc, Eugen, et al.
Publicado: (2021)

Perioperative management of a patient with hemophilia A and crigler-najjar syndrome
por: Bhoi, Debesh, et al.
Publicado: (2013)

A Rare Case Report of Crigler Najjar Syndrome Type II
por: Abdul Raffay, Eusha, et al.
Publicado: (2021)

Crigler-Najjar syndrome type 2: Novel UGT1A1 mutation
por: Nair, Karippoth Mohandas, et al.
Publicado: (2012)

p.Cys223Tyr mutation causing Crigler–Najjar syndrome type II
por: Xiong, Qing‐Fang, et al.
Publicado: (2020)

Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expression
por: Karadagi, Ahmad, et al.
Publicado: (2017)

Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome
por: Collaud, Fanny, et al.
Publicado: (2018)

A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome
por: Ronzitti, Giuseppe, et al.
Publicado: (2016)

Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler–Najjar Syndrome
por: Aronson, Sem J., et al.
Publicado: (2019)

Liver Transplantation in a Child With Crigler-Najjar Syndrome Type I: A Case Report With Review of the Literature
por: Alharbi, Faisal A, et al.
Publicado: (2023)

Acute cholangitis in an old patient with Crigler-Najjar syndrome type II - a case report
por: Fernandes, Samuel Raimundo, et al.
Publicado: (2016)

Severe neonatal hyperbilirubinemia in Crigler‐Najjar syndrome model mice can be reversed with zinc protoporphyrin
por: Fujiwara, Ryoichi, et al.
Publicado: (2017)

Novel combined UGT1A1 mutations in Crigler Najjar Syndrome type I
por: Abdellaoui, Nawel, et al.
Publicado: (2022)

Mild Crigler–Najjar Syndrome with Progressive Liver Disease—A Multicenter Retrospective Cohort Study
por: Junge, Norman, et al.
Publicado: (2023)

AAV8 Gene Therapy for Crigler-Najjar Syndrome in Macaques Elicited Transgene T Cell Responses That Are Resident to the Liver
por: Greig, Jenny A., et al.
Publicado: (2018)

Promoterless gene targeting without nucleases rescues lethality of a Crigler‐Najjar syndrome mouse model
por: Porro, Fabiola, et al.
Publicado: (2017)

Determining the Minimally Effective Dose of a Clinical Candidate AAV Vector in a Mouse Model of Crigler-Najjar Syndrome
por: Greig, Jenny A., et al.
Publicado: (2018)

Hereditary Spherocytosis Coexisting with UDP-Glucuronosyltransferase Deficiency Highly Suggestive of Crigler-Najjar Syndrome Type II
por: Iijima, Shigeo, et al.
Publicado: (2011)

Spectrum of UGT1A1 Variations in Chinese Patients with Crigler-Najjar Syndrome Type II
por: Li, Lufeng, et al.
Publicado: (2015)

Perioperative Management of Patient with Esophageal Carcinoma and Crigler-Najjar Syndrome Type 2: A Case Report
por: Ma, Dehua, et al.
Publicado: (2022)

A rare case of Crigler–Najjar syndrome type 2: A case report and literature review
por: Rijal, Divas, et al.
Publicado: (2023)

Molecular Analysis of the UGT1A1 Gene in Korean Patients with Crigler-Najjar Syndrome Type II
por: Ko, Jae Sung, et al.
Publicado: (2014)

Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome
por: Gailite, Linda, et al.
Publicado: (2018)

Lipid nanoparticle-encapsulated mRNA therapy corrects serum total bilirubin level in Crigler-Najjar syndrome mouse model
por: Greig, Jenny A., et al.
Publicado: (2023)

UGT1A1 Gene Mutation due to Crigler-Najjar Syndrome in Iranian Patients: Identification of a Novel Mutation
por: Mohammadi Asl, Javad, et al.
Publicado: (2013)

Gilbert or Crigler–Najjar syndrome? Neonatal severe unconjugated hyperbilirubinemia with P364L UGT1A1 homozygosity
por: Cozzi, Laura, et al.
Publicado: (2022)

Free Bilirubin Induces Neuro-Inflammation in an Induced Pluripotent Stem Cell-Derived Cortical Organoid Model of Crigler-Najjar Syndrome
por: Pranty, Abida Islam, et al.
Publicado: (2023)

Truncated UDP-glucuronosyltransferase (UGT) from a Crigler–Najjar syndrome type II patient colocalizes with intact UGT in the endoplasmic reticulum
por: Suzuki, Masahiro, et al.
Publicado: (2014)

Case report: Crigler-Najjar syndrome type 1 in Croatia—more than a one in a million: a case series
por: Kovačić Perica, Matea, et al.
Publicado: (2023)

Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer
por: Bortolussi, Giulia, et al.
Publicado: (2012)

Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice
por: Famulari, Elvira Smeralda, et al.
Publicado: (2020)

Procurement and Evaluation of Hepatocytes for Transplantation From Neonatal Donors After Circulatory Death
por: Bluhme, Emil, et al.
Publicado: (2022)

Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II
por: Sun, Lei, et al.
Publicado: (2017)

CORRIGENDUM: Quantitative Systems Pharmacology Model of hUGT1A1‐modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler‐Najjar Syndrome Type 1
por: Apgar, J.F., et al.
Publicado: (2020)

Quantitative Systems Pharmacology Model of hUGT1A1‐modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler‐Najjar Syndrome Type 1
por: Apgar, Joshua F., et al.
Publicado: (2018)

Update on a previously reported missense mutation: The c.1160 C>A mutation in the UGT1A1 gene result in Crigler–Najjar syndrome type 1
por: Ghorbani, Mohammad Javad, et al.
Publicado: (2021)

UGT1A1 Variants c.864+5G>T and c.996+2_996+5del of a Crigler-Najjar Patient Induce Aberrant Splicing in Minigene Assays
por: Gailite, Linda, et al.
Publicado: (2020)

X-linked ichthyosis and Crigler-Najjar syndrome I: Coexistence in a male patient with two copy number variable regions of 2q37.1 and Xp22.3
por: BAI, JINLI, et al.
Publicado: (2016)

A case report of a novel 22 bp duplication within exon 1 of the UGT1A1 in a Sudanese infant with Crigler-Najjar syndrome type I
por: Valmiki, Sailaja, et al.
Publicado: (2020)

Case report: A rare case of pyruvate kinase deficiency and Crigler-Najjar syndrome type II with a novel pathogenic variant of PKLR and UGT1A1 mutation
por: Wu, Huan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1gblduof1vnnov1t0286ecqqfn